MAPT and Alzheimer disease: miRNAs found in stool can originate from both the host and gut microbiota, and emerging evidence suggests that microbiota-derived miRNAs may influence key processes involved in AD pathology (Aβ accumulation, tau hyperphosphorylation, neuroinflammation, and synaptic degradation) [16].